MEDSURGE Healthcare has been granted Section 19A approval for Aciclovir 3% (30mg/g) eye ointment (pack of 1x4.5g) by the Therapeutic Goods Administration (TGA).
The approval was given to cover the discontinuation of Zovirax ophthalmic ointment.
The TGA has also approved the company for Levodopa 250mg / Carbidopa 25mg and Levodopa 200mg / Carbidopa 50mg controlled release, to cover the long-term unavailability of MSD's Sinemet 250mg/25mg tablets and Sinemet CR 200mg/50mg tablets.
Contact your wholesaler for info.
The above article was sent to subscribers in Pharmacy Daily's issue from 05 Jun 19
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 05 Jun 19
